Key Inflation Data in Focus

U.S. stock futures advanced, extending last week's rally that saw the Nasdaq Composite achieve new all-time highs. Investor focus this week centers on the release of key inflation data (CPI and PPI), as soft readings would bolster expectations for a September Fed rate cut, particularly after recent weak jobs reports and ahead of the Jackson Hole Symposium. Concurrently, Q2 earnings season continues with strong beats from monday.com, Franco-Nevada (65% EPS growth), and Barrick Mining (47% EPS growth), while Legend Biotech reported a wider loss offset by revenue outperformance.

Analysis

The market is exhibiting cautious optimism, with U.S. stock futures advancing after the Nasdaq Composite reached new all-time highs. Investor focus is now acutely centered on this week's forthcoming Consumer Price Index (CPI) and Producer Price Index (PPI) data. A soft reading on inflation is the market's anticipated catalyst, as it would strengthen the case for a Federal Reserve interest rate cut in September, a sentiment already bolstered by unexpectedly weak July employment figures and significant downward revisions to prior months' data. The upcoming Jackson Hole Symposium will be a critical venue for interpreting the Fed's reaction to this new data. On the corporate front, second-quarter earnings have provided a supportive backdrop, particularly in the materials and technology sectors. Gold miners demonstrated exceptional strength, with Franco-Nevada (FNV) reporting a 65% year-over-year increase in adjusted EPS to $1.24 and a 42% revenue surge, while Barrick Mining posted a 47% YoY EPS gain. In software, monday.com (MNDY) surpassed expectations with adjusted earnings of $1.09 per share against an $0.84 estimate. In contrast, the biopharmaceutical space showed a more mixed picture, with Legend Biotech (LEGN) beating revenue forecasts by a notable margin but reporting a wider-than-expected quarterly loss of $0.34 per share.

Key Decisions for Investors

• Investors should closely monitor this week's CPI and PPI releases, as softer-than-expected inflation figures would likely reinforce expectations for a September Fed rate cut and could fuel further market upside.
• The significant year-over-year earnings and revenue growth from Franco-Nevada and Barrick Mining highlights operational strength in the gold mining sector, warranting a review of exposure to materials.
• For growth-focused investors, monday.com's simultaneous beat on earnings and revenue confirms strong execution, whereas Legend Biotech's results require weighing its impressive revenue growth against deteriorating profitability.
• With the Nasdaq trading at all-time highs, it is prudent to evaluate portfolio risk, as market sentiment is highly sensitive to the imminent inflation data and subsequent Fed signaling from the Jackson Hole symposium.